New diabetes clinical trial: Impact of GLP-1 Receptor Agonists on Patients With IPMN
Published on: June 10, 2025 at 11:00PM
Conditions: IPMN; IPMN, Pancreatic; GLP-1; Intraductal Papillary Mucinous Neoplasm of Pancreas; Glucagon-Like Peptide-1 Receptor Agonists
Interventions: Drug: GLP1 receptor agonist
Sponsors: Hôpital Fribourgeois; Insel Gruppe AG, University Hospital Bern; University Hospital, Geneva
Not yet recruiting
https://ift.tt/SB26x1E
Conditions: IPMN; IPMN, Pancreatic; GLP-1; Intraductal Papillary Mucinous Neoplasm of Pancreas; Glucagon-Like Peptide-1 Receptor Agonists
Interventions: Drug: GLP1 receptor agonist
Sponsors: Hôpital Fribourgeois; Insel Gruppe AG, University Hospital Bern; University Hospital, Geneva
Not yet recruiting
https://ift.tt/SB26x1E
Comments
Post a Comment